Pandit Kaushik, Goswami Soumik, Ghosh Sujoy, Mukhopadhyay Pradip, Chowdhury Subhankar
Department of Endocrinology, Institute of Post Graduate Medical Education and Research and SSKM Hospital, Kolkata, India.
Indian J Endocrinol Metab. 2012 Jan;16(1):44-55. doi: 10.4103/2230-8210.91187.
South Asia is home to one of the largest population of people with metabolic syndrome (MetS). The prevalence of MetS in South Asians varies according to region, extent of urbanization, lifestyle patterns, and socioeconomic/cultural factors. Recent data show that about one-third of the urban population in large cities in India has the MetS. All classical risk factors comprising the MetS are prevalent in Asian Indians residing in India. The higher risk in this ethnic population necessitated a lowering of the cut-off values of the risk factors to identify and intervene for the MetS to prevent diabetes and cardiovascular disease. Some pharmacological and nonpharmacological interventions are underway in MetS to assess the efficacy in preventing the diabetes and cardiovascular disease in this ethnic population.
南亚是代谢综合征(MetS)患者人数最多的地区之一。南亚地区MetS的患病率因地区、城市化程度、生活方式模式以及社会经济/文化因素而异。最新数据显示,印度大城市中约三分之一的城市人口患有MetS。构成MetS的所有经典风险因素在居住在印度的亚洲印度人中都很普遍。该种族人群较高的患病风险使得有必要降低风险因素的临界值,以识别和干预MetS,预防糖尿病和心血管疾病。目前正在对MetS进行一些药物和非药物干预,以评估其在预防该种族人群糖尿病和心血管疾病方面的疗效。